
Generative AI is quickly becoming part of everyday healthcare operations. Organizations are using AI to automate documentation, summarize medical records, assist with coding, support patient communication, and improve administrative workflows.
Choosing the right AI platform, however, involves much more than comparing features and pricing. If an AI vendor will create, receive, maintain, or transmit Protected Health Information (PHI), healthcare organizations have a responsibility to evaluate the vendor's security, privacy, and compliance practices before signing a contract.
A thorough vendor due diligence process helps reduce compliance risks, strengthen security, and build confidence that the AI solution can support healthcare requirements.
This checklist outlines the practical questions every healthcare organization should ask when evaluating a generative AI vendor.
Not every AI platform is designed for healthcare.
Many consumer AI services have different privacy practices, data retention policies, and contractual terms than enterprise offerings. Assuming every version of an AI product provides the same protections can expose organizations to unnecessary risk.
Vendor due diligence helps answer critical questions such as:
The goal is to verify vendor claims with documentation rather than relying solely on marketing materials.
A Business Associate Agreement is one of the first items to discuss if the AI system will handle PHI.
Ask the vendor:
Request evidence such as:
Do not assume a vendor offers a BAA for every product or subscription tier.
Understanding how the vendor handles customer data is essential.
Questions to ask include:
Request evidence such as:
Healthcare organizations should seek clear answers rather than relying on general statements about privacy.
Knowing how long information remains in vendor systems is critical.
Ask:
Request evidence including:
Organizations should ensure retention practices align with their own policies and regulatory obligations.
Security should be evaluated using objective evidence.
Questions include:
Ask for supporting evidence such as:
Strong technical safeguards help reduce the likelihood of unauthorized access.
Audit logs are important for investigating incidents and supporting compliance efforts.
Ask whether the platform records:
Also ask:
Request sample audit logs or documentation showing available logging capabilities.
Many AI vendors rely on additional service providers.
Healthcare organizations should understand exactly who participates in processing customer data.
Questions include:
Request:
Visibility into the vendor's supply chain is an important part of due diligence.
Security testing should extend beyond traditional software assessments.
Ask the vendor:
Request evidence such as:
Vendors may not share full reports, but they should be prepared to explain their testing approach and remediation process.
Ask how AI risks are identified and managed throughout the product lifecycle.
Questions may include:
Evidence may include:
A mature governance program demonstrates that AI risks are managed continuously rather than only during product development.
Healthcare organizations should understand how privacy is integrated into the vendor's operations.
Questions include:
Supporting evidence may include:
Remember that no vendor can make your organization HIPAA compliant through technology alone. Compliance depends on both the vendor's capabilities and your organization's implementation.
Every vendor should have a documented process for responding to security events.
Ask:
Request:
Clear communication during an incident can significantly reduce operational disruption.
Responsible AI extends beyond cybersecurity.
Ask vendors how they manage:
Organizations should understand how governance supports the ongoing reliability of the AI system.
A strong due diligence package often includes:
Not every vendor will provide every document, but reputable vendors should be transparent about their security and privacy practices.
Healthcare organizations often make avoidable mistakes during vendor evaluations.
These include:
A structured review process helps reduce these risks.
Selecting a generative AI vendor is not simply a technology decision. It is also a privacy, security, and risk management decision.
A thorough due diligence process helps healthcare organizations verify that vendors have appropriate contractual protections, technical safeguards, governance practices, and security controls before patient information is involved. Requesting evidence such as Business Associate Agreements, data retention policies, audit logging documentation, subprocessor lists, and AI security testing summaries provides a stronger basis for evaluating vendor claims.
Vendor due diligence should also be viewed as an ongoing process. As AI platforms evolve, organizations should periodically review contracts, security documentation, governance practices, and product updates to ensure the solution continues to meet operational and compliance expectations. Building this discipline into your vendor management program can reduce risk while supporting the responsible adoption of AI across healthcare.
Have a project in mind? We'd love to hear about it. Tell us what you're building and let's explore what's possible.
hello@globalnodes.com
+91 9873388887